US Broker Ratings

Quest Diagnostics (DGX) Stock Analysis: Steady Growth and a 6.34% Upside Potential

For individual investors seeking exposure to the healthcare sector, Quest Diagnostics Incorporated (NYSE: DGX) presents a compelling opportunity. With a market capitalization of $19.79 billion, Quest..

Doximity, Inc. (DOCS) Stock Analysis: A Healthcare Innovator with a Steady Growth Trajectory

Doximity, Inc. (DOCS) stands out as a key player in the healthcare sector, operating as a digital platform tailored for medical professionals. With a robust market..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Analyst Ratings Signal a 22% Upside Potential

GE HealthCare Technologies Inc. (NYSE: GEHC) has garnered significant attention in the healthcare sector, boasting a robust market capitalization of $32.87 billion and a diverse portfolio..

Haleon plc (HLN) Stock Analysis: Exploring a 21.66% Upside Potential in the Healthcare Sector

Haleon plc (HLN), a prominent player in the global healthcare industry, presents a compelling opportunity for investors seeking exposure to the drug manufacturing sector, specifically within..

Zimmer Biomet Holdings, Inc. (ZBH): Investor Outlook with an 11.74% Upside Potential

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) continues to draw significant attention from investors keen on the healthcare sector, particularly those focused on medical devices. With a..

Viatris Inc. (VTRS) Stock Analysis: Unpacking a 16.35% Potential Upside for Investors

In the realm of healthcare investments, Viatris Inc. (NASDAQ: VTRS) presents a unique case for investors seeking both opportunity and challenge. With a market capitalization of..

STERIS plc (STE) Stock Analysis: Unlocking a 12.16% Upside Potential with Strong Analyst Confidence

Investors eyeing opportunities within the healthcare sector may find STERIS plc (NYSE: STE) a compelling addition to their portfolios. The company, with a robust market capitalization..

ResMed Inc. (RMD) Stock Analysis: Strong Growth Potential with a 25.86% Return on Equity

ResMed Inc. (NYSE: RMD), a leader in medical devices and cloud-based software solutions for respiratory disorders, continues to captivate investors with its robust growth metrics and..

Waters Corporation (WAT) Stock Analysis: Unveiling a 27% Upside Potential in the Healthcare Sector

Waters Corporation (NYSE: WAT), a leader in the diagnostics and research industry, stands as a formidable player in the healthcare sector. With a market capitalization of..

Hologic, Inc. (HOLX) Stock Analysis: Navigating Potential Upside in the Healthcare Sector

Hologic, Inc. (NASDAQ: HOLX), a key player in the healthcare sector, continues to capture the attention of investors with its comprehensive offerings in the medical instruments..

Align Technology, Inc. (ALGN) Stock Analysis: Potential Upside of 33% for Patient Investors

Align Technology, Inc. (NASDAQ: ALGN), a leader in the healthcare sector specializing in medical instruments and supplies, is making waves among investors with its innovative orthodontic..

Encompass Health Corporation (EHC) Stock Analysis: A 14.82% Upside on the Horizon?

Encompass Health Corporation (NYSE: EHC) is gaining considerable attention from investors, particularly those focused on the healthcare sector. With a market capitalization of $11.84 billion, this..

West Pharmaceutical Services, I (WST)

⚠️ No article content returned.

..

AbbVie Inc. (ABBV) Stock Analysis: Evaluating Growth Potential with a Strong Dividend Yield

AbbVie Inc. (NYSE: ABBV), a prominent player in the healthcare sector, presents a compelling case for investors with its formidable market presence and robust financial performance...

Royalty Pharma plc (RPRX) Stock Analysis: Uncovering a Potential 15% Upside in the Biotechnology Sector

Royalty Pharma plc (NASDAQ: RPRX) stands as a pivotal player in the biotechnology sector, renowned for its unique business model of acquiring biopharmaceutical royalties and funding..

Incyte Corporation (INCY): Investor Outlook Highlights Growth Potential with 16.5% Revenue Increase

Incyte Corporation (NASDAQ: INCY), a prominent player in the biotechnology sector, stands out with its recent 16.5% revenue growth, showcasing robust performance in the healthcare industry...

Abbott Laboratories (ABT) Stock Analysis: Navigating a 6.11% Upside in the Healthcare Sector

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare industry, commands a market cap of $233.71 billion, underscoring its significant presence in the medical devices sector...

HCA Healthcare, Inc. (HCA) Stock Analysis: Evaluating a Robust 13,631.68% ROE and What It Means for Investors

HCA Healthcare, Inc. (NYSE: HCA) stands as a titan in the U.S. healthcare sector with an impressive market capitalization of $89.29 billion. As a key player..

The Cooper Companies, Inc. (COO) Stock Analysis: A 32.69% Upside Beckons in the Healthcare Sector

The Cooper Companies, Inc. (NYSE: COO), a prominent player in the healthcare sector, has captured the attention of investors with its robust portfolio of medical instruments..

BioNTech SE (BNTX) Stock Report: Unpacking a 23% Potential Upside Amidst Robust Revenue Growth

BioNTech SE (NASDAQ: BNTX), a prominent player in the biotechnology sector, has captured investor attention with its impressive revenue growth and promising pipeline of immunotherapies. Headquartered..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds